Your browser doesn't support javascript.
loading
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers.
Malekzadeh, Parisa; Pasetto, Anna; Robbins, Paul F; Parkhurst, Maria R; Paria, Biman C; Jia, Li; Gartner, Jared J; Hill, Victoria; Yu, Zhiya; Restifo, Nicholas P; Sachs, Abraham; Tran, Eric; Lo, Winifred; Somerville, Robert Pt; Rosenberg, Steven A; Deniger, Drew C.
Afiliação
  • Malekzadeh P; Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Pasetto A; Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Robbins PF; Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Parkhurst MR; Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Paria BC; Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Jia L; Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Gartner JJ; Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Hill V; Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Yu Z; Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Restifo NP; Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Sachs A; Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Tran E; Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Lo W; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Somerville RP; Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Rosenberg SA; Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Deniger DC; Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
J Clin Invest ; 129(3): 1109-1114, 2019 03 01.
Article em En | MEDLINE | ID: mdl-30714987

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno HLA-A2 / Proteína Supressora de Tumor p53 / Neoplasias Epiteliais e Glandulares / Cadeias beta de HLA-DP / Mutação / Antígenos de Neoplasias Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: J Clin Invest Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno HLA-A2 / Proteína Supressora de Tumor p53 / Neoplasias Epiteliais e Glandulares / Cadeias beta de HLA-DP / Mutação / Antígenos de Neoplasias Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: J Clin Invest Ano de publicação: 2019 Tipo de documento: Article